Cyclacel Pharma (CYCC) Reports Q1 Loss Per Share of $0.19
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.19), versus ($0.25) reported last year. Revenue for the quarter came in at $512 thousand, versus $396 thousand reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- Freedom Broker Starts Citizens Inc. (CIA) at Buy
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
